Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23945217 | 0.83 | — | — | |
| SCHEMBL5018097 | 0.82 | TDP1 (0.54) | TDP1 | |
| SCHEMBL24090520 | 0.71 | TDP1 (0.41) | TDP1 | |
| SCHEMBL25907409 | 0.69 | TDP1 (0.47) | TDP1 | |
| SCHEMBL25907405 | 0.69 | TDP1 (0.47) | TDP1 | |
| SCHEMBL19531760 | 0.69 | TDP1 (0.47) | TDP1 | |
| SCHEMBL19592229 | 0.69 | TDP1 (0.39) | TDP1 | |
| SCHEMBL14072954 | 0.67 | TDP1 (0.37) | TDP1 | |
| SCHEMBL19729482 | 0.67 | TDP1 (0.44) | TDP1 | |
| SCHEMBL25906248 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023193313-A1 | AMINO ACID POLYMER, AND PREPARATION METHOD THEREFOR AND USE THEREOF AS NATURAL GAS HYDRATE KINETIC INHIBITOR | 北京大学 | 2023-10-12 | — | — | WO | disclosed |
| US-20230158169-A1 | LINKERS FOR IMPROVING THE STABILITY OF BIOCONJUGATES AND THE SELECTIVITY OF PAYLOAD RELEASE | AUDAX PRIVATE DEBT LLC, AS AGENT | 2023-05-25 | — | — | US | disclosed |
| US-11510994-B2 | Linkers for improving the stability of bioconjugates and the selectivity of payload release | EqIP, LLC (US) | 2022-11-29 | — | — | US | disclosed |
| US-7420059-B2 | HMG-CoA reductase inhibitors and method | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11510994-B2 | Linkers for improving the stability of bioconjugates and the selectivity of payload release | CTSA, CTSS, CTSV | TDP1 1350/4885 |
| US-20230158169-A1 | LINKERS FOR IMPROVING THE STABILITY OF BIOCONJUGATES AND THE SELECTIVITY OF PAYLOAD RELEASE | CTSA, CTSS, CTSV | TDP1 1350/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.